|
| Code | Diagnosis | Comment | Score |
| anonymous | Metaplastic carcinoma (100%) | nil | 100 |
| anonymous | metaplastic carcinoma: carcinosarcoma | nil | 100 |
| anonymous | Metaplastic carcinoma (carcinosarcoma) 100% | nil | 100 |
| anonymous | metaplastic with heterologous differentiation or carcinosarcoma 100% | nil | 100 |
| anonymous | Metaplastic carcinoma (with angiosarcomatous and liposarcomatous components)90%; Malignant phyllodes tumor 5%; Primary mammary sarcoma 5% | Further sampling for more typical invasive ductal carcinoma or phyllodes tumor areas. | 100 |
| anonymous | METAPLASTIC CARCINOMA(SARCOMATOID CARCINOMA) 100% | Cytokeratin may be positive in the sarcomatoid component. | 100 |
| anonymous | Metaplastic carcinoma. (100%) | nil | 100 |
| anonymous | Metaplastic carcinoma 100% | nil | 100 |
| anonymous | Metaplastic carcinoma, 100% | nil | 100 |
| anonymous | Metaplastic carcinoma, 95%. | Differential diagnosis includes high grade sarcomas (5%), e.g. malignant fibrous histiocytoma. More blocks may be sampled and immunohistochemical studies are advised. A panel of antibodies, including cytokeratin, actin, desmin, S-100, LCA, HMB 45, etc may be useful. | 100 |
| anonymous | metaplastic carcinoma | nil | 100 |
| anonymous | Metaplastic Carcinoma (100%) | nil | 100 |
| anonymous | Metaplastic carcinoma 100% | nil | 100 |
| anonymous | Metaplastic carcinoma | May need extensive sampling to exclude a component of phylloides tumor. | 100 |
| anonymous | Metaplastic carcinoma | nil | 100 |
| anonymous | Metaplastic carcinoma (100% probability) | nil | 100 |
| anonymous | Metaplastic carcinoma, without heterologous element (100%) | Both sarcomatous and epithelial components may coexpress cytokeratin. Metastasis usually consists of epithelial component. | 95 |
| anonymous | SORRY FOR A MISTAKEN SUBMISSION. BUT WE DID NOT RECEIVE THIS BATCH OF SLIDES. | THE SITE FOR FILING CME ALSO HAS SOME PROBLEMS | 0 |